Last edition
News about
Zynex Receives FDA Clearance for Next-Gen M-Wave Neuromuscular Stimulation Device
The M-Wave, successor to the renowned E-Wave, revolutionizes NMES treatments with enhanced functionality and a user-friendly design.
Sibel Health's ANNE One Receives 4th FDA Clearance for Continuous Wearable Vital Signs Monitoring
This latest clearance expands the capabilities of the ANNE® One platform to include continuous ambulatory ECG monitoring, SpO2, temperature, and non-invasive blood pressure measurements.
Thermax Acquires TSA Process Equipments
Thermax has signed definitive agreements for acquisition to be completed in due course and will fully acquire the balance stake of the company over the next two years.
AstraZeneca Invests USD 300 Million in Cutting-Edge Cell Therapy Facility in Rockville, MD
The site, strategically located within Maryland's flourishing life sciences corridor and near universities, underscores AstraZeneca's commitment to innovation and talent recruitment.
Empower Pharma Acquires East Windsor Facility for Pharmaceutical Expansion
The companies anticipate completing the transaction in the coming months, subject to the satisfaction of closing conditions.
Zuellig Pharma Introduces Volvo FE Electric Truck for Cold Chain Logistics
Marking the group's 100-year anniversary, CEO John Chou reaffirmed Zuellig Pharma's dedication to powering a sustainable future for the next century.
The distribution agreement includes KRONOS products for Brenntag Specialties’ customers in Life Science segments, which include pharmaceutical as well as cosmetics and personal care applications.
SGD Pharma Launches Type I Tubular Vials with Corning's 'Velocity Vial' Coating Technology
The new range comprises high-quality Type I injectable vials crafted from tubular glass, now equipped with a low-friction coating that optimizes performance during the fill and finish process.
Zuellig Pharma Expands Healthcare Portfolio with Acquisition of Cialis and Alimta Brands
The acquisition covers Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, and Thailand through its wholly-owned subsidiary, Zanovex Pte. Ltd.
Aurobindo Pharma's US Subsidiary Eugia to Sell Business Assets for USD 52 Million
The agreement encompasses Eugia's related assets, liabilities, and employees, as the company strategically focuses on enhancing capacities and operations in other units.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy